AC-262536
CAS No. 870888-46-3
AC-262536( AC 262536 | AC262536 )
Catalog No. M27843 CAS No. 870888-46-3
AC-262536 is a selective androgen receptor (SAR) modulator and exhibits potent agonist activity at the androgen receptor.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
Size | Price / USD | Stock | Quantity |
2MG | 35 | Get Quote |
|
5MG | 58 | Get Quote |
|
10MG | 102 | Get Quote |
|
25MG | 222 | Get Quote |
|
50MG | 380 | Get Quote |
|
100MG | 565 | Get Quote |
|
500MG | 1215 | Get Quote |
|
1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameAC-262536
-
NoteResearch use only, not for human use.
-
Brief DescriptionAC-262536 is a selective androgen receptor (SAR) modulator and exhibits potent agonist activity at the androgen receptor.
-
DescriptionAC-262536 is a selective androgen receptor (SAR) modulator and exhibits potent agonist activity at the androgen receptor. It has partial agonist activity with respect to testosterone and suppresses luteinizing hormone.(In Vitro):AC-262536 inhibits dihydroxytestosterone (DHT)-induced proliferation of LNCaP in a dose-dependent manner. The effects are significant with 100 nM, and reaches a plateau with 1 μM.(In Vivo):In male sprague-dawley rats, administration of AC-262536 (subcutaneous injection, once daily for 14 consecutive days) significantly decreased LH levels by about 40% at the 3 mg/kg dose. At the 10 and 30 mg/kg doses, the effects of AC-262536 were significantly stronger than Testosterone Propionate (TP) : 1.91±0.32 ng/mL and 1.53±0.34 ng/mL vs. 3.12±0.69 ng/mL, respectively.
-
In VitroAC-262536 dose-dependently inhibits dihydroxytestosterone (DHT)-induced proliferation of LNCaP. The effects are significant with 100 nM AC-262536 (%inhibition 47.2±12.2), and reaches a plateau with 1 μM treatment (%inhibition 50.7±7.6). Thus, AC-262536 can act as a functional antagonist in prostate cells.
-
In VivoAC-262536 (3, 10, 30 mg/kg) reverses the luteinizing hormone (LH) spike in castrated rats. Animal Model:Male Sprague-Dawley rats (200-225 g)Dosage:3, 10 and 30 mg/kg Administration:Administered subcutaneously; once daily for 14 consecutive days Result:Significantly decreased LH levels by about 40% at the 3 mg/kg dose.The ED50 was determined to be 2.8 mg/kg.At the 10 and 30 mg/kg doses, the effects of AC-262536 were significantly stronger than Testosterone Propionate (TP) : 1.91±0.32 ng/mL and 1.53±0.34 ng/mL vs. 3.12±0.69 ng/mL, respectively.
-
SynonymsAC 262536 | AC262536
-
PathwayEndocrinology/Hormones
-
TargetAndrogen Receptor (AR)
-
Recptor——
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number870888-46-3
-
Formula Weight278.355
-
Molecular FormulaC18H18N2O
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 50 mg/mL (179.63 mM)
-
SMILESOC1C[C@@H]2CC[C@H](C1)N2c1ccc(C#N)c2ccccc12
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.El-Sayed, May A.; Al-Gendy, Amal. A.; Hamdan, Dalia. I.; El-Shazly, Assem M. Phytoconstituents, LC-?ESI-?MS profile, antioxidant and antimicrobial activities of Citrus x limon L. Burm. f. Cultivar variegated pink lemon. Journal of Pharmaceutical Sciences and Research (2017), 9(4), 375-391.
molnova catalog
related products
-
Nandrolone phenpropi...
Nandrolone phenpropionate is an androgen receptor agonist. It mainly used to treat women with breast cancer and osteoporosis.
-
2-hydroxy Flutamide
2-hydroxy Flutamide is competitive inhibition of androgen receptor (AR)?for the treatment of prostate cancer.
-
Flutamide
Flutamide is an antiandrogen drug, with its active metablolite binding at androgen receptor.